The Single Best Strategy To Use For active pharmaceutical ingredients
“The present situation has uncovered some structural weaknesses within the EU’s medicines source chain in addition to a superior dependence on non-EU international locations for active pharmaceutical ingredients,” Kyriakides reported. She proposed that supply chain challenges be addressed in an EU pharmaceutical method envisioned for being in